Scott Dreyer insider trades
Open-market stock purchases and sales by Scott Dreyer, EVP & Chief Commercial Officer at Collegium Pharmaceutical, Inc, from SEC Form 4 filings since Jul 10, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 3, 2026 | COLL Collegium Pharmaceutical, Inc | Sold | $1.9M |
| Mar 3, 2026 | COLL Collegium Pharmaceutical, Inc | Sold | $146K |
| Feb 10, 2026 | COLL Collegium Pharmaceutical, Inc | Bought (not open market) | — |
| Feb 10, 2026 | COLL Collegium Pharmaceutical, Inc | Bought (not open market) | — |
| Feb 10, 2026 | COLL Collegium Pharmaceutical, Inc | Sold (not open market) | $466K |
| Feb 10, 2026 | COLL Collegium Pharmaceutical, Inc | Sold (not open market) | $1M |
| Dec 8, 2025 | COLL Collegium Pharmaceutical, Inc | Sold | $533K |
| Dec 8, 2025 | COLL Collegium Pharmaceutical, Inc | Sold | $315K |
| Dec 8, 2025 | COLL Collegium Pharmaceutical, Inc | Bought (not open market) | — |
Companies traded
- COLL Collegium Pharmaceutical, Inc: 32 sales, last Mar 3, 2026